Connecting Partners, Empowering Growth | Getein Hosts India Distributor Meeting

Strengthening Partnerships in India

Getein Biotech, together with its local partner Ares Labs, hosted the 2026 India Distributor Meeting on August 20 2026, at SK Premium Park in New Delhi.

Held under the theme "Grow Together, Win the Future," the meeting brought together representatives from leading diagnostic companies across India. Partners and industry professionals exchanged insights, explored opportunities for collaboration, and discussed the future of India's diagnostics market.

The event provided an open platform for closer cooperation. It also highlighted Getein's commitment to bringing reliable, high-performance in vitro diagnostic (IVD) solutions to Indian healthcare institutions while supporting the development of local laboratory capabilities.

Guests arrived in the afternoon and took part in informal conversations before the meeting began. The event officially opened at 5:00 p.m. with remarks from Getein's overseas sales team, who thanked all partners for their continued trust and support.

Technology Showcase

During the main session, the Getein team introduced the company's expertise and latest developments across three product lines: chemiluminescence, point-of-care testing (POCT), and hematology.

The fully automated MAGICL 6000 and MAGICL 6000i chemiluminescence immunoassay analyzers are designed to meet laboratories' different throughput requirements, offering a balance of efficiency, accuracy, and reliability.

Getein's POCT portfolio ranges from portable semi-automated devices to fully automated, high-throughput systems. These solutions support a variety of settings, including emergency care, decentralized testing, and central laboratories.

The BHA series of hematology analyzers includes both 3-part and 5-part differential models, providing complete blood count solutions for a broad range of clinical applications.The BHA series of hematology analyzers includes both 3-part and 5-part differential models, providing complete blood count solutions for a broad range of clinical applications.

Participants showed strong interest in the products' technical performance and clinical value. Discussions covered reagent stability, assay menus, equipment capabilities, and laboratory implementation, creating an engaging and productive atmosphere.

Clinical Insights

The open discussion session focused on practical needs in the Indian market. Participants shared their experience with hospital laboratories and clinical workflows and raised questions about equipment maintenance, testing efficiency, and local service support.

These exchanges offered valuable insights into local operating conditions and provided a basis for further cooperation between Getein and its Indian partners.

Growing Together

India is one of the world's most dynamic diagnostics markets, with significant potential for continued growth. Getein Biotech will continue to work closely with trusted local partners to provide reliable, high-performance IVD products to healthcare institutions across the country.

The successful meeting strengthened local partners' understanding of the Getein brand and product portfolio, further supporting the company's development in the Indian market.

Looking ahead, Getein will continue to expand its international business, provide comprehensive and efficient IVD solutions, and organize more academic and product-focused exchange activities. Through these efforts, the company aims to support progress in global healthcare.

Together for a healthier future.